Humor as effective as medication in treating agitation in dementia

	Tweet

Humour therapy is as effective as widely used antipsychotic drugs in managing agitation in patients with dementia – and avoids serious drug side effects, a new study to be presented this week at the National Dementia Research Forum shows.

The first major study of the impact of humour therapy on mood, agitation, behavioural disturbances and social engagement in dementia patients found both short term and persisting decrease in agitation, according to lead researcher, Dr Lee-Fay Low, a Research Fellow at UNSW’s School of Psychiatry.

The SMILE study across 36 Australian residential aged care facilities involved the recruitment and training of a staff member to act as a “LaughterBoss” who worked with a humour practitioner with comedic and improvisation skills – not unlike “Clown Doctors” used in hospitals to aid recovery and lift mood in children.

Jean-Paul Bell, the key humour therapist in the SMILE study, has set up the Arts Health Institute (AHI) to train humour practitioners and aged care staff. The AHI’s core program, Play Up, provides a playful relationship with residents and staff in aged care, focusing particularly with people with dementia. The AHI is now focused on translating the knowledge of the SMILE study into residential aged care and continues to work with UNSW’s Dementia Collaborative Research Centre to roll out the program nationally.

Dementia rates are expected to double to in the next 20 years in Australia to about 450,000, mainly due to an ageing population. About 6.5 per cent of people over 65 and 22 per cent of people over 85 have dementia – an umbrella term used to describe up to 60 different conditions causing similar neurodegenerative changes in the brain.

Between 70 and 80 per cent of people suffering from dementia are troubled by agitation, a problem for both patients with the disease and their carers.

“Agitated behaviours include physical and verbal aggression, wandering, screaming and repetitive behaviours and questions. This is challenging for staff and often indicates unmet needs and distress in the residents of aged care facilities,” says Dr Low.

The SMILE study found a 20 per cent reduction in agitation using humour therapy, an improvement comparable to the common use of anti-psychotic drugs.

“This shows humour therapy should be considered before medication for agitation, particularly taking into account its side effects.”

A major 2009 study for the UK Department of Health found serious side effects of antipsychotics, including thousands of deaths and strokes, linked to the use of these drugs in dementia and recommended a reduction in medication rates and specialised training for carers in non-drug therapies.

In the SMILE study agitation decreased not only during the 12 week humour therapy program, but remained lower at 26 week follow up. Happiness and positive behaviours rose over the 12 weeks of the program, however, dropped as soon as humour practitioner visits ceased.

The SMILE Study results will be presented at the National Dementia Research Forum 2011 on Thursday and Friday (22- 23 Sept). A documentary film, The Smile Within, produced by Hot Tin Productions and based on the SMILE Study, will also be screened.

A free public talk “Alzheimers and You? Prevention and Treatment of Dementia” will be held tonight (Sept 21 at 6.00-7.30pm) at the Wesley Conference Centre, 220 Pitt Street, in Sydney.

Full details can be found here.

A free screening of The Smile Within will be held at the Bondi Pavilion Seagull Room on Thursday 22 September, 11am. The screening will be followed by a short panel discussion.

###
RSVP

Media contact: Steve Offner, UNSW Media Office | 02 9385 8107

RELATED STORIES:
Alcohol intake in the elderly affects risk of cognitive decline and dementia   REM Sleep Disorder Doubles Risk of Mild Cognitive Impairment, Parkinson’s, Study Finds   Early sign of Alzheimer’s reversed in lab   Colonoscopy or flexible sigmoidoscopy may be used to predict Parkinson’s   Is Alzheimer’s Caused by Contagious Proteins?   Nicotine Patch Shows Benefits in Mild Cognitive Impairment   Special report: With Alzheimer’s in the genes, when do you test?   Gladstone scientist finds new target for treating symptoms of Parkinson’s disease   Top scientist slams Australia’s dementia funding   Most cases of dementia are not diagnosed: report   What to do if you suspect Alzheimer’s   Parkinson’s Disease Stopped in Animal Model   Why do neurons die in Parkinson’s disease?   Cognitive decline can begin as early as age 45, warn experts   World Alzheimer’s Report 2011: The benefits of early diagnosis and intervention

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]